Literature DB >> 30688313

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation.

Javier A Jaimes1, Jean K Millet2, Monty E Goldstein3, Gary R Whittaker4, Marco R Straus5.   

Abstract

Enveloped viruses such as coronaviruses or influenza virus require proteolytic cleavage of their fusion protein to be able to infect the host cell. Often viruses exhibit cell and tissue tropism and are adapted to specific cell or tissue proteases. Moreover, these viruses can introduce mutations or insertions into their genome during replication that may affect the cleavage, and thus can contribute to adaptations to a new host. Here, we present a fluorogenic peptide cleavage assay that allows a rapid screening of peptides mimicking the cleavage site of viral fusion proteins. The technique is very flexible and can be used to investigate the proteolytic activity of a single protease on many different substrates, and in addition, it also allows exploration of the activity of multiple proteases on one or more peptide substrates. In this study, we used peptides mimicking the cleavage site motifs of the coronavirus spike protein. We tested human and camel derived Middle East Respiratory Syndrome coronaviruses (MERS-CoV) to demonstrate that single and double substitutions in the cleavage site can alter the activity of furin and dramatically change cleavage efficiency. We also used this method in combination with bioinformatics to test furin cleavage activity of feline coronavirus spike proteins from different serotypes and strains. This peptide-based method is less labor- and time intensive than conventional methods used for the analysis of proteolytic activity for viruses, and results can be obtained within a single day.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30688313     DOI: 10.3791/58892

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  13 in total

1.  Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site.

Authors:  Javier Jaimes; Jean Millet; Gary Whittaker
Journal:  SSRN       Date:  2020-05-05

2.  Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.

Authors:  Xingguang Li; Junjie Zai; Qiang Zhao; Qing Nie; Yi Li; Brian T Foley; Antoine Chaillon
Journal:  J Med Virol       Date:  2020-03-11       Impact factor: 2.327

Review 3.  A Tale of Two Viruses: The Distinct Spike Glycoproteins of Feline Coronaviruses.

Authors:  Javier A Jaimes; Jean K Millet; Alison E Stout; Nicole M André; Gary R Whittaker
Journal:  Viruses       Date:  2020-01-10       Impact factor: 5.048

4.  Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike.

Authors:  Bailey Lubinski; Maureen H V Fernandes; Laura Frazier; Tiffany Tang; Susan Daniel; Diego G Diel; Javier A Jaimes; Gary R Whittaker
Journal:  iScience       Date:  2021-12-10

5.  Cryptococcal Protease(s) and the Activation of SARS-CoV-2 Spike (S) Protein.

Authors:  Nozethu Mjokane; Maphori Maliehe; Olufemi S Folorunso; Adepemi O Ogundeji; Onele M N Gcilitshana; Jacobus Albertyn; Carolina H Pohl; Olihile M Sebolai
Journal:  Cells       Date:  2022-01-27       Impact factor: 6.600

6.  A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.

Authors:  Tanmoy Mondal; Gururaj Shivange; Alaa Habieb; Jogender Tushir-Singh
Journal:  Microbiol Spectr       Date:  2022-02-09

7.  SARS-CoV-2: International Investigation Under the WHO or BWC.

Authors:  Mirko Himmel; Stefan Frey
Journal:  Front Public Health       Date:  2022-02-03

8.  Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda.

Authors:  Bailey Lubinski; Laura E Frazier; My V T Phan; Daniel L Bugembe; Jessie L Cunningham; Tiffany Tang; Susan Daniel; Matthew Cotten; Javier A Jaimes; Gary R Whittaker
Journal:  bioRxiv       Date:  2022-03-28

9.  Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site.

Authors:  Javier A Jaimes; Jean K Millet; Gary R Whittaker
Journal:  iScience       Date:  2020-05-28

10.  Human matriptase/ST 14 proteolytically cleaves H7N9 hemagglutinin and facilitates the activation of influenza A/Shanghai/2/2013 virus in cell culture.

Authors:  Gary R Whittaker; Marco R Straus
Journal:  Influenza Other Respir Viruses       Date:  2019-12-09       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.